BICO 2030 Strategy

The BICO 2030 strategy sharpens our focus on the areas where we have the strongest competitive advantage and the clearest opportunities for sustainable, profitable growth. 

At the core of this strategy is Precision Biology. We define Precision Biology as the technologies and workflows that enable life-science laboratories to generate more predictive, reproducible and biologically relevant data. Our capabilities span the precise handling, culture, automation and analysis of biological material. 

 

With the new strategy, BICO will focus on areas where we have a clear right to win, with cell-based applications in biotech and pharma as our lead market and a particular focus on cell solutions and the adoption of advanced 3D cell models.

Strategic Priorities for the Group

01.

Precision Biology at the core

Concentrate resources on cell solutions and 3D cell models, where BICO’s competitive advantage is strongest. 

  • Accelerate organic growth 
  • Increase the share of consumables, services and software 
  • Reduce exposure to large, customized projects

02.

Customer-driven innovation, enabled by AI

Align R&D more closely with customer demand, using AI in product development, making instruments ready for software, agents and robots, and incorporating AI into the products themselves.

  • Higher returns on R&D 
  • Faster development 
  • Software revenue on the installed base 

03.

Accountability close to the customer

Business units own growth, profitability and execution, supported by lean Group functions. 

  • Stronger commercial execution 
  • Increased operating leverage 

Contact us!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.